Anagram Partners advised CVC on the sale of a majority stake in Healthcare Global Enterprises to KKR for ~USD 400 million.

CVC has signed a definitive agreement for the sale of CVC Asia V’s majority stake in Healthcare Global Enterprises (HCG) to KKR. As per the agreement, CVC will sell a 54% stake (approx.) in HCG at a purchase price of INR 445 per share to KKR.

CVC is a leading global private markets manager with a network of 29 offices throughout EMEA, the Americas, and Asia, with approx. €193 billion worth of assets under management.

Founded in 1989, HCG is one of India’s largest oncology hospital chains. Through its network of 25 comprehensive cancer centers, HCG provides advanced technologies for the effective diagnosis and treatment of cancer under one roof.

KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds.

Anagram Partners acted as the legal advisor to CVC on this transaction. The team was led by our Partners, Shuva Mandal, Ankit Mishra, Aditi Tralshawala and comprised Sanskriti Singh and Jagdish Kaisare.

Read more at:

CVC agrees the sale of up to 54% stake in Healthcare Global Enterprises for up to US$400m | CVC

KKR to Buy Majority Stake in India’s HCG for $400 Million – Bloomberg